» Articles » PMID: 34478872

Downregulation of a Mitochondrial Micropeptide, MPM, Promotes Hepatoma Metastasis by Enhancing Mitochondrial Complex I Activity

Overview
Journal Mol Ther
Publisher Cell Press
Date 2021 Sep 3
PMID 34478872
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

We and others have shown that MPM (micropeptide in mitochondria) regulates myogenic differentiation and muscle development. However, the roles of MPM in cancer development remain unknown. Here we revealed that MPM was downregulated significantly in human hepatocellular carcinoma (HCC) tissues and its decrease was associated with increased metastasis potential and HCC recurrence. Gain- and loss-of-function investigations disclosed that in vitro migration/invasion and in vivo liver/lung metastasis of hepatoma cells were repressed by restoring MPM expression and increased by silencing MPM. Mechanism investigations revealed that MPM interacted with NDUFA7. Mitochondrial complex I activity was inhibited by overexpressing MPM and enhanced by siMPM, and this effect of siMPM was attenuated by knocking down NDUFA7. The NAD/NADH ratio, which was regulated by complex I, was reduced by MPM but increased by siMPM. Treatment with the NAD precursor nicotinamide abrogated the inhibitory effect of MPM on hepatoma cell migration. Further investigations showed that miR-17-5p bound to MPM and inhibited MPM expression. miR-17-5p upregulation was associated with MPM downregulation in HCC tissues. These findings indicate that a decrease in MPM expression may promote hepatoma metastasis by increasing mitochondrial complex I activity and the NAD/NADH ratio.

Citing Articles

Mitoregulin Promotes Cell Cycle Progression in Non-Small Cell Lung Cancer Cells.

Stein C, Linzer C, Heer C, Witmer N, Cochran J, Spitz D Int J Mol Sci. 2025; 26(5).

PMID: 40076565 PMC: 11899852. DOI: 10.3390/ijms26051939.


Non-canonical ORFs-derived protein products in mitochondria: A multifaceted exploration of their functions in health and disease.

Ajala I, Vanderperre B Protein Sci. 2025; 34(3):e70053.

PMID: 39969119 PMC: 11837024. DOI: 10.1002/pro.70053.


Mitoregulin self-associates to form likely homo-oligomeric pore-like complexes.

Linzer C, Stein C, Witmer N, Xu Z, Schnicker N, Boudreau R iScience. 2025; 28(1):111554.

PMID: 39811642 PMC: 11732159. DOI: 10.1016/j.isci.2024.111554.


Early Diagnosis of Tumorigenesis via Ratiometric Carbon Dots with Deep-Red Emissive Fluorescence Based on NAD Dependence.

Cui L, Lou W, Sun M, Wei X, Yang S, Zhang L Molecules. 2024; 29(22.

PMID: 39598697 PMC: 11596318. DOI: 10.3390/molecules29225308.


Emerging role of endogenous peptides encoded by non-coding RNAs in cancer biology.

Tornesello A, Cerasuolo A, Starita N, Amiranda S, Cimmino T, Bonelli P Noncoding RNA Res. 2024; 10:231-241.

PMID: 39554691 PMC: 11567935. DOI: 10.1016/j.ncrna.2024.10.006.


References
1.
Huang J, Chen M, Chen D, Gao X, Zhu S, Huang H . A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth. Mol Cell. 2017; 68(1):171-184.e6. DOI: 10.1016/j.molcel.2017.09.015. View

2.
Chng S, Ho L, Tian J, Reversade B . ELABELA: a hormone essential for heart development signals via the apelin receptor. Dev Cell. 2013; 27(6):672-80. DOI: 10.1016/j.devcel.2013.11.002. View

3.
Makarewich C, Baskin K, Munir A, Bezprozvannaya S, Sharma G, Khemtong C . MOXI Is a Mitochondrial Micropeptide That Enhances Fatty Acid β-Oxidation. Cell Rep. 2018; 23(13):3701-3709. PMC: 6066340. DOI: 10.1016/j.celrep.2018.05.058. View

4.
Huang Q, Chen Z, Cheng P, Jiang Z, Wang Z, Huang Y . LYRM2 directly regulates complex I activity to support tumor growth in colorectal cancer by oxidative phosphorylation. Cancer Lett. 2019; 455:36-47. DOI: 10.1016/j.canlet.2019.04.021. View

5.
Santidrian A, Matsuno-Yagi A, Ritland M, Seo B, LeBoeuf S, Gay L . Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J Clin Invest. 2013; 123(3):1068-81. PMC: 3582128. DOI: 10.1172/JCI64264. View